K. Kumar Sankhala MD
Gynecologic Cancer, Sarcoma, Thoracic Cancer
Advanced Cancers and Sarcoma Medical Oncology Clinical Research and Experimental Therapuitics
Join to View Full Profile
9100 Wilshire Blvd Ste 840wBeverly Hills, CA 90212
Phone+1 424-777-0708
Fax+1 424-421-2522
Dr. Sankhala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2010 - 2012- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2010
Dr. S.N. Medical CollegeClass of 1997, MBBS
U Texas HSC- Institute for Drug Development
Certifications & Licensure
TX State Medical License 2011 - 2026
CA State Medical License 2011 - 2025
American Board of Internal Medicine Medical Oncology
American Board of Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- AACR-NCI Scholarship for “Molecular Biology in Clinical Oncology” workshop AACR-NCI, 2007
- The American Society of Clinical Oncology Foundation Merit Award ASCO, 2005
Clinical Trials
- Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 3 citationsPilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma.Santosh Kesari, Naveed Wagle, Jose A Carrillo, Akanksha Sharma, Minhdan Nguyen
Clinical Cancer Research. 2024-01-17 - 26 citationsCombined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination.Sol Lee, Kamalesh K Sankhala, Swaraj Bose, Ron P Gallemore
International Medical Case Reports Journal. 2022-01-01 - 20 citationsA Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.Florence Atrafi, Oliver Boix, Vivek Subbiah, Jennifer R. Diamond, Sant P. Chawla
Clinical Cancer Research. 2021-09-13
Press Mentions
When Surgery Isn’t an Option, This Knee Tumor May Still Be TreatedFebruary 13th, 2025
Committees
- Board Member, Institutional Review Board (IRB) 2018 - 2020
- Board Member, Disease Research Group 2017 - 2020
- Board Member, Protocol Review and Monitoring Committee 2017 - 2018
- Member, Pharmacy Utilization Management Committee 2011 - 2013
Professional Memberships
- Member
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
